Your institution may have access to this item. Find your institution then sign in to continue.
Title
Patients with bipolar II disorder benefit from single dose of psilocybin.
Abstract
A single 25‐mg dose of psilocybin resulted in improvement in depressive symptoms in all 15 participants in an open‐label nonrandomized trial enrolling adults with bipolar II disorder. Twelve of the 15 participants met response and remission criteria at the study's 12‐week endpoint.